Featured Publications
Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis. An Official American Thoracic Society Research Statement
Sears CR, Peikert T, Possick JD, Naidoo J, Nishino M, Patel SP, Camus P, Gaga M, Garon EB, Gould MK, Limper AH, Montgrain PR, Travis WD, Rivera MP. Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis. An Official American Thoracic Society Research Statement. American Journal Of Respiratory And Critical Care Medicine 2019, 200: e31-e43. PMID: 31518182, PMCID: PMC6775885, DOI: 10.1164/rccm.201906-1202st.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsImmune checkpoint inhibitorsICI-pneumonitisCheckpoint inhibitorsOfficial American Thoracic Society Research StatementUse of ICIsLife-threatening pneumonitisUnique adverse eventsBiological mechanismsAdverse eventsRadiologic featuresRadiologic presentationCancer careBiologic mechanismsResearch prioritiesBasic biological mechanismsMultidisciplinary groupPneumonitisClinical researchersDiagnosisInhibitorsPrecipitous increaseTherapyAvailable dataCarePulmonary Toxicities from Checkpoint Immunotherapy for Malignancy
Possick JD. Pulmonary Toxicities from Checkpoint Immunotherapy for Malignancy. Clinics In Chest Medicine 2017, 38: 223-232. PMID: 28477635, DOI: 10.1016/j.ccm.2016.12.012.ChaptersPulmonary Complications of Lung Cancer Treatment
McAvoy K, Possick J. Pulmonary Complications of Lung Cancer Treatment. Respiratory Medicine 2023, 229-254. DOI: 10.1007/978-3-031-38412-7_11.ChaptersPulmonary complicationsTreatment-related risk factorsNonspecific respiratory symptomsLife-saving therapyLung cancer treatmentLung cancer therapyUnderstanding of patientsRespiratory symptomsRadiographic findingsAttendant complicationsDiagnostic challengeRisk factorsTreatment paradigmRadiation therapyTraditional chemotherapyComplicationsAccurate diagnosisAreas of uncertaintyCancer treatmentTherapyCancer therapyDisease responsePatientsImmunotherapyChemotherapy
2018
Should Physicians New to a Case Counsel Patients and Their Families to Change Course at the End of Life?
Honiden S, Possick J. Should Physicians New to a Case Counsel Patients and Their Families to Change Course at the End of Life? The AMA Journal Of Ethic 2018, 20: e699-707. PMID: 30118419, DOI: 10.1001/amajethics.2018.699.Commentaries, Editorials and LettersConceptsGoals of careLife care optionsPhysician practice variationEnd of lifeAdvanced malignanciesCounsel patientsCritical illnessOncology patientsNew cancer therapiesCare discussionsIndividual patientsPractice variationCare plansComfort measuresPhysician objectionPatientsCare optionsPhysiciansCancer therapyClinical momentumPotential benefitsPrognosisMalignancyTherapyIllness